Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19-Reference-Cited by-同舟云学术

Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19

Published:2020-06-19 Issue:7 Volume:7 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Thompson III George R¹²,Cornely Oliver A³⁴⁵⁶^ORCID,Pappas Peter G⁷,Patterson Thomas F⁸⁹,Hoenigl Martin¹⁰¹¹^ORCID,Jenks Jeffrey D¹⁰,Clancy Cornelius J¹²¹³,Nguyen M Hong¹³

Affiliation:

1. Department of Internal Medicine, University of California Davis Medical Center, Davis, California, USA

2. Division of Infectious Diseases and Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Davis, California, USA

3. Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany

4. German Centre for Infection Research (DZIF) partner site Bonn-Cologne, Cologne, Germany

5. CECAD Cluster of Excellence, University of Cologne, Cologne, Germany

6. Clinical Trials Center Cologne, University Hospital of Cologne, Cologne, Germany

7. Department of Internal Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA

8. University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

9. South Texas Veterans Health Care System, San Antonio, Texas, USA

10. Division of Infectious Diseases and Global Health, University of California San Diego, La Jolla, California, USA

11. Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria

12. VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA

13. Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Abstract

Pulmonary aspergillosis has been increasingly reported following severe respiratory viral infections. Millions have been infected by SARS-CoV-2, placing large numbers of patients at-risk for COVID-19 associated pulmonary aspergillosis (CAPA). Prompt recognition of this syndrome and is paramount to improve outcomes.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofaa242/33404778/ofaa242.pdf

Reference37 articles.

1. Full spectrum of COVID-19 severity still being depicted;Xu;Lancet,2020

2. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China;Wang;JAMA,2020

3. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State;Arentz;JAMA,2020

4. Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China;Cao;Clin Infect Dis

5. Covid-19 in critically ill patients in the Seattle region - case series;Bhatraju;N Engl J Med,2020

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis;Contemporary Clinical Trials Communications;2024-06

2. Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review;Mycopathologia;2024-01-17

3. A rare case of meningoencephalitis due to <i>Aspergillus fumigatus</i>;Working Paper of Public Health;2023-07-26

4. Mortality in ICU Patients with COVID-19-Associated Pulmonary Aspergillosis;Journal of Fungi;2023-06-20

5. Characterization of Aspergillus spp. isolated from patients with coronavirus disease 2019;Journal of Infection and Chemotherapy;2023-06